Circulating miR-122 as a potential biomarker of liver disease. - Wikidata - awgldk - TriplyDB

Circulating miR-122 as a potential biomarker of liver disease.

Circulating miR-122 as a potential biomarker of liver disease.

http://www.wikidata.org/entity/Q45194892

about

Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise Alcoholic hepatitis and HCV interactions in the modulation of liver disease Assay reproducibility in clinical studies of plasma miRNA MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.MicroRNAs as biomarkers in pituitary tumors.Circulating miRNAs as biomarkers for endocrine disorders.Circulating RNA: looking at the liver through a frosted glass.Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.The Hepatoprotective and MicroRNAs Downregulatory Effects of Crocin Following Hepatic Ischemia-Reperfusion Injury in Rats.The release of microRNA-122 during liver preservation is associated with early allograft dysfunction and graft survival after transplantation.Alcohol-mediated miR-34a modulates hepatocyte growth and apoptosis.

P2860

Q24289207-92F263E0-DAE1-4B15-8C90-6A31954B2886 Q28082378-129D1C88-1309-490E-8C57-F9C1BEB05829 Q28084063-90254036-D3C2-4C94-8804-28B5FEF36C61 Q35325816-E0287C87-935E-4502-B28F-48BA7A5C6BC8 Q35750622-3B215D9C-725A-4FBD-A18B-344BA5EDB181 Q36022680-0717C6E7-ABA3-4FB1-85F8-6BD31241B1E7 Q38205084-A81F38DB-EFD4-4C09-8F93-F69E54CCCF08 Q38503895-36B9F21A-D9A1-40CD-8E50-91BE88F56394 Q38652065-3E467EE8-529B-4907-9A2B-4105090334DB Q38718486-1C943996-75E0-4E83-AD01-68C3BFDE503D Q40268702-6C100882-E8FD-42F6-A6A8-0B88D571E76C Q48303643-7DA8AD32-576B-4D13-B998-89D55BA60175 Q54976906-456C1245-2410-4E79-BF37-8473D129A1D0

P2860

Circulating miR-122 as a potential biomarker of liver disease.

http://www.wikidata.org/entity/Q45194892

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Circulating miR-122 as a potential biomarker of liver disease.

@en

Circulating miR-122 as a potential biomarker of liver disease.

@nl

type

label

Circulating miR-122 as a potential biomarker of liver disease.

@en

Circulating miR-122 as a potential biomarker of liver disease.

@nl

prefLabel

Circulating miR-122 as a potential biomarker of liver disease.

@en

Circulating miR-122 as a potential biomarker of liver disease.

@nl

P1433

Q45194892-41981C1F-3CD5-4ED8-9725-FF21958ABD71

P1476

Q45194892-0CB5EA7A-3FC8-4254-B2D4-AEEA3DF31343

P2093

Q45194892-63C5EC1A-A0C8-46B6-BEF0-03867E42BDEE

Q45194892-7A7BED25-CEC3-4AB1-A485-23ADFA836A13

Q45194892-85551243-C6DA-415D-A312-20379A2C60A0

Q45194892-F102EEC8-C8DA-466D-A6C3-D81A9D0D5981

P2860

Q45194892-100C96A1-6C75-48F5-8107-6B0CADB4F798

Q45194892-10C9E0DD-AA7B-4400-8D44-0C26CC3F6406

Q45194892-1D7C5155-4ED3-439A-B4E5-B36BBBECBB3C

Q45194892-1FDDE499-D30D-4EC8-A361-CACAFA25300E

Q45194892-2CD93D63-C566-4EB2-A364-325E42EBBADF

Q45194892-2E1241B5-73C9-436D-970A-2E32BB918A51

Q45194892-2E69F273-CDB0-4CD9-94F6-04513CC41884

Q45194892-3440EABE-B8C2-4014-948B-A438AFAB6189

Q45194892-34B436C7-6C02-4E88-8AE2-BF5103BA0FC3

Q45194892-34F0D168-D156-41DC-B2F0-47AAF542448C

P304

Q45194892-0996E298-0331-4093-A9F2-D34B3EF57A36

P31

Q45194892-81D5EE22-D932-4474-84B8-F37F274064AD

P356

Q45194892-7BB42271-333A-4BEC-9709-5D8B297CE28D

P433

Q45194892-B0F9B785-5E22-480A-9E07-C291BC963EA0

P478

Q45194892-3F954B83-5A79-4574-A286-BDBA8D647EEC

P50

Q45194892-1129127B-2C61-45EB-AC00-4B4966599219

P577

Q45194892-1AC3CAF6-DB21-463A-B007-032F076B17F8

P698

Q45194892-97F30AED-5FD4-44A3-B12F-3A2755D53AF1

P921

Q45194892-C07FF478-5186-4E37-9C49-5FC860A51544

P356

P1433

Biomarkers in Medicine

P1476

Circulating miR-122 as a potential biomarker of liver disease.

@en

P2093

Kevin M Korenblat

http://www.w3.org/2001/XMLSchema#string

Mitchell G Scott

http://www.w3.org/2001/XMLSchema#string

Omar F Laterza

http://www.w3.org/2001/XMLSchema#string

Philip W Garrett-Engele

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs in lipid metabolism

microRNAs and cholesterol metabolism

Circulating microRNAs as stable blood-based markers for cancer detection.

Circulating microRNAs, potential biomarkers for drug-induced liver injury

Identification of tissue-specific microRNAs from mouse

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis.

Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases.

P304

205-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.12.107

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Christina M. Lockwood

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23547815

http://www.w3.org/2001/XMLSchema#string

P921